← Leaderboards
Takahiro Yano
Vironika, Llc
$1,449,278
Attributed
$1,599,278
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $569.1K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,599,278 · 3
By mechanism
R43$1,599,278 · 3
Top collaborators
- Nelson Delgado1 shared
Most similar at Vironika, Llc
Same institution · by research overlap
- Troy E Messick$3,405,267
- Ursula D Ramirez$900,001
- Nelson Delgado$150,000
Others in their field
Other Emerging Leaders on “Viral”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$160,855,334
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,911,178
- John Damon Chodera · Sloan-Kettering Inst Can Research$51,025,260
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- Thomas Denny · Duke University$37,546,967
Research focus
ViralHigh Throughput ScreeningPreventStructureSmall MoleculeQuantitative Structure-Activity RelationshipPharmaceutical ChemistryPharmacodynamicsScreeningSmall Molecule InhibitorLeadLibrariesAnimal ModelSmall Business Innovation Research GrantBindingCellsBiochemicalDrug KineticsBaseMedicalLatent InfectionMalignant NeoplasmsMeetingsHuman Herpesvirus 4
Grant awards (6)
Discovery of inhibitors of EBV lytic cycle inducing protein ZTA for therapeutic development$130,205
R43 · FY2023 · AI · contact PI
Targeting HIV transcription with RNA-binding small molecules$300,000
R43 · FY2022 · AI · contact PI
Discovery of inhibitors of EBV lytic cycle inducing protein ZTA for therapeutic development$269,073
R43 · FY2022 · AI · contact PI
Targeting HIV transcription with RNA-binding small molecules$300,000
R43 · FY2021 · AI
Development of a Small Molecule Inhibitor to Eradicate HSV Latent Infection in Neurons$300,000
R43 · FY2020 · AI · contact PI
Development of a Small Molecule Inhibitor to Eradicate HSV Latent Infection in Neurons$300,000
R43 · FY2019 · AI · contact PI